Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Classical hematology 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 12Leukemia, Myeloid, Acute 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Lymphoma, Mantle-Cell 6Leukemia, Lymphocytic, Chronic, B-Cell 6Congenital Abnormalities 6Leukemia, Myelomonocytic, Acute 5Leukemia, Monocytic, Acute 5Leukemia, Erythroblastic, Acute 5Lymphoma, Large B-Cell, Diffuse 4Lymphoma, Follicular 4Lymphoma 4Leukemia, Megakaryoblastic, Acute 4Waldenstrom Macroglobulinemia 3Prostatic Neoplasms 3Lymphoma, Non-Hodgkin 3Lymphoma, B-Cell, Marginal Zone 3Burkitt Lymphoma 3Sarcoma 2Pancreatic Neoplasms 2Neoplasms 2Multiple Myeloma 2Melanoma 2Lymphoma, Large-Cell, Immunoblastic 2Breast Neoplasms 2Blast Crisis 2Wilms Tumor 1Tumor Lysis Syndrome 1Thromboembolism 1Thrombocytopenia 1

Interventions

eltrombopag 8romiplostim 5Cytarabine 4Filgrastim 3Etoposide 3Daunorubicin 3Carboplatin 3oprelvekin 2fludarabine phosphate 2avatrombopag 2Thrombopoietin 2Radiotherapy 2Peripheral Blood Stem Cell Transplantation 2Lenalidomide 2Interleukin-11 2Ifosfamide 2Doxorubicin 2Cyclosporine 2Busulfan 2sargramostim 1ofatumumab 1lusutrombopag 1leridistim 1bryostatin 1 1angiotensin I (1-7) 1alvocidib 1Vitamin E 1Vitamin B 12 1Vincristine 1Tranexamic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Thrombocytopenia × alvocidib × Clear all
NCT00735930 2015-04-02

Lenalidomide and Alvocidib in Treating Patients With Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

National Cancer Institute (NCI)

Phase 1 Completed
39 enrolled
Classical hematologyLymphoidOther hematologic neoplasm

Anemia, Thrombocytopenia, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡